Company Filing History:
Years Active: 2011-2013
Title: Innovations of Cheng-Jen Chou in Cancer Research
Introduction
Cheng-Jen Chou is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research through his innovative patents. With a total of two patents to his name, his work focuses on methods for inhibiting tumor cell growth.
Latest Patents
Chou's latest patents include a method for the inhibition of tumor cell growth using (22R)-5α-lanosta-8,24-dien-3β,15α,21-triol. This patent describes the isolation of a novel compound from the fruiting body, which exhibits preferential cytotoxicity against various cancer cells, including those associated with human leukemia, pancreatic cancer, esophageal cancer, hepatoma, and cervical cancer. Another significant patent relates to a method using dehydrosulphurenic acid to inhibit the growth of leukemia and pancreatic cancer cells. This compound can be utilized as a pharmaceutical composition to effectively inhibit tumor growth.
Career Highlights
Cheng-Jen Chou is affiliated with Mackay Memorial Hospital, where he continues to advance his research in oncology. His work has garnered attention for its potential impact on cancer treatment and patient outcomes.
Collaborations
Chou collaborates with esteemed colleagues, including Yu-Jen Chen and Tun-Tschu Chang, who contribute to his research endeavors.
Conclusion
Cheng-Jen Chou's innovative work in cancer research highlights the importance of developing new methods for tumor inhibition. His contributions are paving the way for advancements in cancer therapies and improving the lives of patients affected by this disease.